BMP — BMP Pharma Trading AG Income Statement
0.000.00%
- €29.14m
- €29.26m
- €0.00m
- 22
- 36
- 17
- 12
Annual income statement for BMP Pharma Trading AG, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | GAS | GAS | GAS | GAS | GAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.001 | 0.004 | 0.002 | 0 | 0.002 |
Cost of Revenue | |||||
Gross Profit | 0 | 0.001 | -0.001 | 0 | 0 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 0.696 | 0.799 | 1.18 | 1.93 | 1.98 |
Operating Profit | -0.694 | -0.795 | -1.18 | -1.93 | -1.98 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 0.298 | 3.21 | 2.22 | 4.09 | 4.19 |
Provision for Income Taxes | |||||
Net Income After Taxes | 0.17 | 2.62 | 1.57 | 2.75 | 2.88 |
Net Income Before Extraordinary Items | |||||
Net Income | 0.17 | 2.62 | 1.57 | 2.75 | 2.88 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 0.17 | 2.62 | 1.57 | 2.75 | 2.88 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.032 | 0.499 | 0.299 | 0.524 | 0.548 |
Dividends per Share |